SCREENING OF DRUG RELATED PROBLEMS IN HIV PATIENTS RECEIVING ANTI RETROVIRAL THERAPY
Aim: The main aim of the study is prospective screening of drug related problems in ART receiving patients at RIMS Kadapa. Objectives: The key objectives of the study include To identify various drug related problems using various domains as per PCNE (Pharmaceutical care network Europe). To identify the most common ART regimen causing DRP. Methodology: A prospective observational study conducted for a period of six months november2015-april 2016. The data was collected by using Patient Data Collection Form, PCNE classification V5.01, Drug interaction form, ADR form. The collected data was analysed for age and gender distribution, distribution of patients based on co morbidities, patients with and without DRPs based on type of ART regimen used, distribution of problems, causes for different problems, interventions suggested for different problems then outcome of interventions were calculated. Results: A total of 125 patients 104 members experienced DRPs with ART regimens, which accounts 63(60.57%) males and 41(39.42%) females. Out of 104 patients 59 members experienced DRPs with ZLN regimen. In those patients the main DRPs were adverse drug reactions, drug use problems and drug interactions. The main causes for those problems were Pharmacokinetic problems incl. Ageing/ deterioration in organ function and interactions (C1.4), manifest side effect no other cause (C1.8) as per PCNE scheme V5.01. The various interventions suggested for those problems were Patient (medication) counselling (I2.1), Instructions for use changed to......(I3.4), new drug started(I3.6). the outcomes for suggested interventions were problems( Rashes, muscle pain, vomiting, nausea, headache, cough, abdominal pain.....etc.) totally solved(O1.0) and problems (Neutropenia, anaemia, hyper pigmentation of skin & nails, ear impairment, severe anaemia, finger paralysis, blurred vision.....etc.) were partially solved(O2.0). Conclusion: Our study concludes adverse drug reactions with ART are high in problems domain as per PCNE, which can be decreased by identifying DRPs in early stages of drug therapy, prescribing other drugs cautiously in HIV patients. Majority of DRPs can be decreased by improving patient-physician relationships and patient-pharmacist relationships. For better outcomes patient counselling can be considered as a better interventional tool which will improve adherence and decrease DRPs in HIV patients.
Keywords: Pharmaceutical Care Network Europe, Drug related problems, Anti retro viral therapy
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356:1255-1259.
3. International monitoring of adverse reactions to drugs. Adverse reaction terminology. Uppsala: WHO Collaborating Centre for International Drug Monitoring, 2002.
4. PCNE classification scheme for drug related problems V1.2. Available at: http://www.pcne.org/upload/files/12_PCNE_classification_V1.pdf (accessed on 06/07/2016).
5. PCNE classification scheme for drug related problems V2.04. Available at: http://www.pcne.org/upload/files/13_PCNE_classification_V2-04.pdf (accessed on 06/07/2016)
6. PCNE classification scheme for drug related problems V3.01. Available at: http://www.pcne.org/upload/files/14_PCNE_classification_V3-01.pdf (accessed on 06/07/2016)
7. PCNE Classification scheme for Drug-Related Problems V4.00. Available at: http://www.pcne.org/upload/files/15_PCNE_classification_V4-00.pdf (accessed on 06/07/2016)
8. PCNE Classification scheme for Drug-Related Problems V5.01. Available at: http://www.pcne.org/upload/files/16_PCNE_classification_V5.01.pdf (accessed on 06/01/2016)
9. Lieketseng J Masenyetse, Samuel OM Manda et al. An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa. AIDS Research and Therapy. 2015; 12:6.
10. Srikanth AB, Babu SC et al. Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy. J Adv Pharm Technol Res. 2012; 3:62â€“7.
11. Languluri Reddenna, Shaik Ayub Basha et al. Highly active antiretroviral therapy: incidence of adverse drug reactions. IJAMSCR. 2013;1(1):25-30.
12. Ramanjireddy Tatiparthi, Yitagesu Mamo et al. Prevalence of ADRs and associated factors of antiretroviral treatment on HIV positive adults at Jush. Indian Journal of Pharmacy Practice. 2014; 7(4).
13. B. Divakar, S. D. Mistry et al. The study of adverse drug reactions (ADRs) in HIV patients taking highly active antiretroviral therapy in art centre, nch, surat, india. IJMPS. 2012; 03(02):9-18.
14. Visanou Hansana, Pattara Sanchaisuriya et al. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR. BMC Public Health. 2013; 13(617): 1-11.
15. Caroline de Godoi Rezende, Costa Molino et al. Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection. Therapeutics and clinical risk management. 2014; 10:631â€“639.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).